Amphastar Pharmaceuticals, Inc.
AMPH· Nasdaq
AMPHAmphastar Pharmaceuticals, Inc.
Filed May 14, 2015 · 10-Q · 44 days after period end · 0001171843-15-002835
| Metric | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|
| Revenue | $56.89M | $45.87M | $52.96M |
| Net Income | -$665.00K | -$1.62M | $2.38M |
| EPS Diluted | -$0.01 | -$0.04 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amphastar Pharmaceuticals, Inc. · CIK 1297184 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 14, 2015 · 44 d after period end
